Latest Leadership News

Native Mineral Resources has raised A$10 million through a share placement to fund the ramp-up of gold production at its Blackjack plant in Queensland, following its first gold pour ahead of schedule.

Siren Gold reveals promising expansion and development prospects at its Sams Creek Project in New Zealand, with recent drilling uncovering new mineralised zones and a mining permit decision expected by year-end.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

AdNeo Limited has fast-tracked $1.5 million in cost savings from its Learnt Group acquisition, hitting key milestones early and setting the stage for significant revenue growth.

Kinatico Limited has reported a record FY25 revenue of $32.1 million, driven by a remarkable 54% increase in SaaS revenue and a cash-positive year despite significant technology investments.

Vitasora Health has completed the first tranche of its $11 million capital raise, positioning the company to fund growth initiatives and reach cash flow breakeven in the second half of fiscal 2026.

FleetPartners has priced a A$400 million asset backed securitisation, featuring a green tranche dedicated to electric vehicle leases, marking a notable step in sustainable finance.

ARC Funds Limited has voluntarily suspended trading on the ASX pending a crucial announcement about its proposed capital raising, signaling a pivotal moment for the investment fund.

DigitalX has raised $20.7 million from leading global digital asset investors to expand its Bitcoin holdings and reinforce its position as a Bitcoin-focused investment manager.

ClearVue Technologies announces key leadership changes with COO Douglas Hunt stepping in as interim CEO, alongside two new board appointments, signaling a strategic push to accelerate growth and innovation.

Platinum Asset Management and L1 Capital have announced a strategic merger to create a diversified investment platform with $16.5 billion in assets under management, promising significant cost synergies and earnings accretion for shareholders.

Argent BioPharma has begun supplying its EU-GMP cannabinoid API for drug-resistant epilepsy treatment at University Medical Centre Ljubljana, marking a key clinical and regulatory milestone in Europe.